Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. URISPAS 200 TABLET 200 MG [SIN12007P]

URISPAS 200 TABLET 200 MG [SIN12007P]

Active ingredients: URISPAS 200 TABLET 200 MG

Last updated 26 October 2025

Product Info

URISPAS 200 TABLET 200 MG

[SIN12007P]

Product information

Active Ingredient and Strength

FLAVOXATE HCL - 200 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - ITALY

Registration Number

SIN12007P

Licence Holder

DCH AURIGA SINGAPORE

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

G04BD02

Uses: Urispas is indicated for the symptomatic relief of dysuria, urgency, nocturia, vesical supra-pubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitits and urethrotrigonitis.

In addition, the preparation is indicated for the relief of vesico-urethral spams due to the catheterization, cystoscopy or indwelling catheters; prior to cystoscopy or catheterization; sequelae of surgical intervention of the lower urinary tract.

Dosage and administration:
Adults (including the elderly): The recommended adult dosage is 200mg three times a day for as long as required.
Children: Not recommended for children under 12 years of age.

Contra-indications:

  • Hypersensitivity to the active substance or to any of the excipients;

  • Gastrointestinal obstructive conditions or ileus;

  • Gastro-intestinal haemorrhage

  • Achalasia

  • Urinary retention

  • Glaucoma.

  • Myasthenia gravis.